Publication Details

Pubmed12832072
Title: The SUMO pathway is required for selective degradation of DNA topoisomerase IIbeta induced by a catalytic inhibitor ICRF-193(1).
Year: 2003
DOI: https://doi.org/10.1016/s0014-5793(03)00637-9
First Author: Isik
Experimental setup: in vitro (Hprd)
in vivo (Hprd)

Interactions

1 interaction
InteractorPartnerSourcesLink
SUMO1_HUMANTOP2A_HUMANHPRDdetails